Publication Name	World Journal of Gastroenterology
Manuscript ID	93476
Country	China

Received	2024-02-28 11:58
Peer-Review Started	2024-02-28 11:58
To Make the First Decision
Return for Revision	2024-07-28 07:00
Revised	2024-08-06 02:14
Second Decision	2024-08-09 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-09 05:14
Articles in Press	2024-08-09 05:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-08-15 05:37
Publish the Manuscript Online	2024-08-27 08:41

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors
Manuscript Source	Invited Manuscript
All Author List	Yu-Nuo Yang, Li-Sheng Wang, Yan-Qi Dang and Guang Ji
ORCID	Author(s) ORCID Number Yan-Qi Dang http://orcid.org/0000-0002-0316-7880 Guang Ji http://orcid.org/0000-0003-0842-3676
Funding Agency and Grant Number	Funding Agency Grant Number National Nature Science Foundation of China 82320108022 Shanghai Rising-Star Program 21QA1409000 Shanghai Frontier Research Base of Disease and Syndrome Biology of Inflammatory Cancer Transformation 2021KJ03-12
Corresponding Author	Guang Ji, MD, PhD, Professor, Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases, Shanghai University of Traditional Chinese Medicine, No. 725 South Wanping Road, Xuhui District of Shanghai, Shanghai 200032, China. jiliver@vip.sina.com
Key Words	Gastric cancer; Immune checkpoint inhibitors; Sarcopenia; Myosteatosis; Prediction model
Core Tip	This study delved into the determinants influencing the efficacy of immune checkpoint inhibitor (ICI) therapy in gastric cancer. Employing COX regression analysis, it crafted a prediction model aimed at enhancing the efficiency and simplicity of evaluating the suitability of immunotherapy. These findings offer novel perspectives for the judicious utilization of ICIs, contributing to improved treatment decision-making and patient care.
Publish Date	2024-08-27 08:41
Citation	<p>Yang YN, Wang LS, Dang YQ, Ji G. Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors. <i>World J Gastroenterol</i> 2024; 30(32): 3726-3729</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i32/3726.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i32.3726

Full Article (PDF)	WJG-30-3726-with-cover.pdf
Manuscript File	93476_Auto_Edited_065000.docx
Answering Reviewers	93476-answering-reviewers.pdf
Audio Core Tip	93476-audio.mp3
Conflict-of-Interest Disclosure Form	93476-conflict-of-interest-statement.pdf
Copyright License Agreement	93476-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	93476-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	93476-non-native-speakers.pdf
Peer-review Report	93476-peer-reviews.pdf
Scientific Misconduct Check	93476-scientific-misconduct-check.png
Scientific Editor Work List	93476-scientific-editor-work-list.pdf
CrossCheck Report	93476-crosscheck-report.pdf